Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 82, 40-50
Abstract
No abstract availableKeywords
Funding Information
- High-Priority Health Projects of Tianjin (16KG146)
- Tianjin Major Science and Technology Projects (17ZXMFSY00200)
This publication has 34 references indexed in Scilit:
- Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participantsDiabetes & Metabolism, 2019
- Mannose Alters Gut Microbiome, Prevents Diet-Induced Obesity, and Improves Host MetabolismCell Reports, 2018
- Metabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic linksHormones, 2018
- Reconsidering betaine as a natural anti-heat stress agent in poultry industry: a reviewTropical Animal Health and Production, 2017
- The metabolism and biotechnological application of betaine in microorganismApplied Microbiology and Biotechnology, 2016
- Methylmalonic acid administration induces DNA damage in rat brain and kidneyMolecular and Cellular Biochemistry, 2014
- Liquid chromatography–mass spectrometry based global metabolite profiling: A reviewAnalytica Chimica Acta, 2012
- Biochemistry of uridine in plasmaClinica Chimica Acta, 2011
- Risk Factors for Type 2 Diabetes MellitusJournal of Cardiovascular Nursing, 2002
- Isoleucine Hydroxamate, an Isoleucine AntagonistJournal of Bacteriology, 1971